Evidence map›Paper›PMID 31933144›Full record

ArticleJournal of cardiovascular translational research2020

A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF).

Rajeev Masson, Andrew P Ambrosy, Kevin Kheder, Marat Fudim, Robert M Clare, Adrian Coles, Adrian F Hernandez, Randall C Starling, Justin A Ezekowitz, Christopher M O'Connor and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rajeev MassonKaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.ORCID 0000-0001-5436-2312
Andrew P AmbrosyKaiser Permanente San Francisco Medical Center, San Francisco, CA, USA. andrew.p.ambrosy@kp.org.
Kevin KhederKaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
Marat FudimDuke University Medical Center, Durham, NC, USA.
Robert M ClareDuke Clinical Research Institute, Durham, NC, USA.
Adrian ColesDuke Clinical Research Institute, Durham, NC, USA.
Adrian F HernandezDuke University Medical Center, Durham, NC, USA.
Randall C StarlingCleveland Clinic Foundation, Cleveland, OH, USA.
Justin A EzekowitzThe Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
Christopher M O'ConnorINOVA Heart and Vascular Institute, Falls Church, VA, USA.
Robert J MentzDuke University Medical Center, Durham, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients hospitalized for heart failure (HF) remain at high risk for early readmission. A post hoc analysis was performed of the biomarker substudy of the ASCEND-HF trial. An in-hospital congestion score was derived using orthopnea, pedal edema, and NT-proBNP levels. Its added prognostic value beyond traditional risk factors was assessed by determining the net reclassification index (NRI). Study participants (n = 884) had a median age (years) of 67 (55-77), 68% were male, and the median (25th-75th) ejection fraction (%) was 26 (20-40). After adjustment, increasing congestion score was associated with 30-day all-cause mortality or HF hospitalization (odds ratio = 1.51, 95% confidence interval [CI] 1.28-1.77, p < 0.001) and 180-day all-cause mortality (hazard ratio = 1.48, 95% CI 1.28-1.72, p < 0.001). However, adding the congestion score to the multivariable model did not significantly impact the NRI. A higher in-hospital congestion score portended a poor short-term prognosis but did not significantly reclassify risk.

Indexed as

Clinical Decision RulesHemodynamicsPatient AdmissionAgedBiomarkersDatabases, FactualDisease ProgressionDyspneaEdemaFemaleHealth StatusHeart FailureHumansMaleMiddle AgedNatriuretic Peptide, BrainBiomarkersNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)CongestionHeart failureMortalityNatriuretic peptidesReadmission

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.